APIXABAN

APIXABAN was reported 68069 times

APIXABAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIOSPASM 415 0.7437
1 IMMUNISATION 267 0.6152
2 PALMOPLANTAR KERATODERMA 408 0.5628
3 SPIROMETRY ABNORMAL 313 0.5234
4 MITE ALLERGY 318 0.4855
5 EJECTION FRACTION 230 0.3959
6 SENSITISATION 279 0.3676
7 MYCOTIC ALLERGY 310 0.3626
8 PULMONARY VASCULITIS 185 0.3439
9 TOTAL LUNG CAPACITY ABNORMAL 130 0.3342
10 DUST ALLERGY 316 0.3221
11 ATRIAL TACHYCARDIA 489 0.2326
12 CONJUNCTIVITIS ALLERGIC 330 0.2227
13 CARDIOVERSION 280 0.2003
14 PRURITUS GENITAL 432 0.1833
15 CARDIAC AMYLOIDOSIS 201 0.1826
16 POLYCYSTIC OVARIES 274 0.1765
17 ATRIAL THROMBOSIS 352 0.1701
18 PERICARDIAL HAEMORRHAGE 348 0.1590
19 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 116 0.1583
20 CARDIAC ABLATION 265 0.1482
21 TRAUMATIC INTRACRANIAL HAEMORRHAGE 133 0.1447
22 HAEMOPERITONEUM 112 0.1398
23 PACKED RED BLOOD CELL TRANSFUSION 185 0.1397
24 HAEMATOMA MUSCLE 167 0.1393
25 CAROTID ARTERY OCCLUSION 490 0.1342
26 AORTIC VALVE DISEASE 202 0.1252
27 AUDITORY DISORDER 164 0.1155
28 ATRIAL FIBRILLATION 10940 0.1122
29 NORMOCHROMIC NORMOCYTIC ANAEMIA 337 0.1121
30 NEURITIS 170 0.1100
31 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 152 0.1082
32 SUBARACHNOID HAEMORRHAGE 1097 0.1076
33 WOUND HAEMORRHAGE 398 0.1075
34 PULMONARY THROMBOSIS 1160 0.1063
35 TENSION HEADACHE 454 0.1055
36 BLOOD LOSS ANAEMIA 237 0.1045
37 SLEEP TERROR 420 0.0996
38 AORTIC VALVE STENOSIS 177 0.0992
39 EMBOLIC STROKE 348 0.0988
40 SYSTEMIC INFECTION 159 0.0958
41 CARDIAC VENTRICULAR THROMBOSIS 122 0.0945
42 HAEMORRHAGE INTRACRANIAL 1412 0.0943
43 THROMBOSIS 7555 0.0938
44 ABDOMINAL WALL HAEMATOMA 179 0.0917
45 EJECTION FRACTION ABNORMAL 112 0.0914
46 ATRIAL FLUTTER 725 0.0908
47 CEREBRAL HAEMATOMA 292 0.0868
48 SINUS NODE DYSFUNCTION 159 0.0867
49 SUBDURAL HAEMATOMA 1234 0.0861
50 CARDIAC VALVE DISEASE 484 0.0846
51 INTRAVENTRICULAR HAEMORRHAGE 210 0.0843
52 OBSTRUCTIVE SLEEP APNOEA SYNDROME 123 0.0843
53 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 172 0.0843
54 BRASH SYNDROME 115 0.0819
55 CEREBELLAR HAEMORRHAGE 117 0.0818
56 PRESCRIBED UNDERDOSE 1632 0.0817
57 ANTIPHOSPHOLIPID SYNDROME 131 0.0814
58 INFUSION SITE HAEMORRHAGE 266 0.0808
59 INTERNAL HAEMORRHAGE 915 0.0800
60 SUBDURAL HAEMORRHAGE 215 0.0785
61 TRANSFUSION 810 0.0772
62 SHOCK HAEMORRHAGIC 623 0.0765
63 DIVERTICULUM INTESTINAL HAEMORRHAGIC 170 0.0756
64 INABILITY TO AFFORD MEDICATION 747 0.0751
65 VASCULAR PSEUDOANEURYSM 130 0.0746
66 TRAUMATIC HAEMORRHAGE 140 0.0743
67 CEREBRAL HAEMORRHAGE 2658 0.0742
68 URINARY BLADDER HAEMORRHAGE 155 0.0736
69 INTRACARDIAC THROMBUS 223 0.0726
70 PULMONARY ALVEOLAR HAEMORRHAGE 406 0.0723
71 HAEMOTHORAX 209 0.0720
72 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 636 0.0719
73 PULMONARY FUNCTION TEST ABNORMAL 112 0.0718
74 HAEMORRHAGE SUBCUTANEOUS 254 0.0715
75 HAEMORRHAGE URINARY TRACT 182 0.0715
76 CATHETER SITE HAEMORRHAGE 176 0.0703
77 VASCULITIS 815 0.0699
78 RHINITIS ALLERGIC 311 0.0698
79 CARDIAC FAILURE CHRONIC 294 0.0689
80 RESPIRATORY SYMPTOM 196 0.0688
81 HAEMATOMA 1778 0.0686
82 FULL BLOOD COUNT ABNORMAL 718 0.0678
83 HAEMORRHOIDAL HAEMORRHAGE 329 0.0673
84 RENAL HAEMORRHAGE 137 0.0673
85 CARDIAC DISORDER 6260 0.0668
86 RETROPERITONEAL HAEMATOMA 146 0.0660
87 LOWER GASTROINTESTINAL HAEMORRHAGE 488 0.0659
88 MELAENA 1413 0.0641
89 DEMENTIA 1793 0.0641
90 HAEMORRHAGIC STROKE 497 0.0636
91 HYPERVOLAEMIA 311 0.0629
92 CARDIAC PACEMAKER INSERTION 365 0.0612
93 DIASTOLIC DYSFUNCTION 188 0.0608
94 GASTROINTESTINAL HAEMORRHAGE 5066 0.0606
95 OXYGEN CONSUMPTION INCREASED 139 0.0581
96 ISCHAEMIC STROKE 1031 0.0577
97 CUTANEOUS VASCULITIS 209 0.0572
98 BLOOD URINE PRESENT 1084 0.0570
99 EAR HAEMORRHAGE 115 0.0568
100 OCCULT BLOOD POSITIVE 110 0.0560
101 HAEMORRHAGE 5772 0.0552
102 RETROPERITONEAL HAEMORRHAGE 136 0.0551
103 POST PROCEDURAL HAEMORRHAGE 639 0.0548
104 LARGE INTESTINAL HAEMORRHAGE 123 0.0547
105 CATHETER SITE ERYTHEMA 117 0.0546
106 TACHYARRHYTHMIA 136 0.0544
107 EPISTAXIS 4052 0.0541
108 ARTERIOSCLEROSIS CORONARY ARTERY 358 0.0540
109 CEREBROVASCULAR ACCIDENT 9076 0.0535
110 FACIAL PAIN 478 0.0535
111 MIXED LIVER INJURY 161 0.0535
112 HAEMATURIA 1826 0.0533
113 VASCULAR DEVICE INFECTION 241 0.0531
114 HAEMORRHAGIC DIATHESIS 179 0.0502
115 UPPER GASTROINTESTINAL HAEMORRHAGE 842 0.0500
116 EMBOLISM VENOUS 151 0.0497
117 HAEMOPTYSIS 1387 0.0497
118 PROCEDURAL HAEMORRHAGE 193 0.0493
119 CARDIAC TAMPONADE 234 0.0492
120 GASTRIC HAEMORRHAGE 566 0.0491
121 WRONG PATIENT RECEIVED PRODUCT 142 0.0485
122 CEREBRAL THROMBOSIS 137 0.0483
123 PULMONARY EMBOLISM 4576 0.0481
124 TRANSIENT ISCHAEMIC ATTACK 1619 0.0479
125 DEVICE INFUSION ISSUE 118 0.0475
126 ADVERSE EVENT 4382 0.0475
127 COVID-19 PNEUMONIA 548 0.0464
128 CEREBRAL INFARCTION 1132 0.0463
129 BENIGN PROSTATIC HYPERPLASIA 239 0.0462
130 INFUSION SITE SWELLING 291 0.0462
131 DYSPNOEA EXERTIONAL 1715 0.0455
132 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 769 0.0452
133 CRANIOCEREBRAL INJURY 137 0.0452
134 INFUSION SITE PAIN 581 0.0450
135 DEEP VEIN THROMBOSIS 2906 0.0447
136 MOUTH HAEMORRHAGE 325 0.0443
137 TUMOUR HAEMORRHAGE 126 0.0441
138 ARTERIOSCLEROSIS 415 0.0441
139 SKIN LACERATION 476 0.0437
140 FORCED EXPIRATORY VOLUME DECREASED 124 0.0437
141 DUODENAL ULCER HAEMORRHAGE 124 0.0433
142 INFUSION SITE ERYTHEMA 365 0.0433
143 TREATMENT NONCOMPLIANCE 2367 0.0432
144 VENTRICULAR TACHYCARDIA 711 0.0430
145 HEART RATE ABNORMAL 240 0.0430
146 OBSTRUCTIVE AIRWAYS DISORDER 471 0.0423
147 GOUT 757 0.0421
148 ANAL HAEMORRHAGE 118 0.0421
149 MUSCLE HAEMORRHAGE 169 0.0421
150 CARDIAC FAILURE 3355 0.0418
151 AORTIC STENOSIS 144 0.0413
152 INTENTIONAL PRODUCT USE ISSUE 3618 0.0413
153 TOOTH DISORDER 918 0.0412
154 IRON DEFICIENCY ANAEMIA 379 0.0410
155 GINGIVAL BLEEDING 556 0.0407
156 LARGE INTESTINE POLYP 282 0.0407
157 DUODENAL ULCER 280 0.0396
158 PULMONARY ARTERIAL HYPERTENSION 574 0.0396
159 BRONCHIECTASIS 265 0.0393
160 CARDIAC FLUTTER 254 0.0393
161 HYPOVOLAEMIC SHOCK 188 0.0392
162 CHEST X-RAY ABNORMAL 120 0.0391
163 CARDIAC FAILURE ACUTE 260 0.0390
164 LEFT VENTRICULAR FAILURE 134 0.0389
165 HYPOACUSIS 1675 0.0389
166 RECTAL HAEMORRHAGE 1667 0.0388
167 DYSPNOEA AT REST 110 0.0379
168 CONJUNCTIVAL HAEMORRHAGE 144 0.0377
169 SKIN ABRASION 177 0.0374
170 CONTUSION 3592 0.0373
171 BRAIN NATRIURETIC PEPTIDE INCREASED 114 0.0369
172 HEAD INJURY 1168 0.0369
173 ORTHOPNOEA 116 0.0364
174 HOSPICE CARE 357 0.0361
175 NEUROLOGICAL SYMPTOM 205 0.0358
176 BLOOD CREATININE ABNORMAL 124 0.0358
177 PULMONARY HYPERTENSION 745 0.0357
178 FLUID RETENTION 1818 0.0357
179 BLOOD TEST ABNORMAL 502 0.0357
180 RIGHT VENTRICULAR FAILURE 247 0.0352
181 WEIGHT FLUCTUATION 367 0.0350
182 RENAL DISORDER 1626 0.0349
183 HAEMATEMESIS 883 0.0348
184 FAECES DISCOLOURED 753 0.0347
185 ECCHYMOSIS 237 0.0345
186 BODY HEIGHT DECREASED 363 0.0339
187 NEPHROGENIC ANAEMIA 157 0.0339
188 SEASONAL ALLERGY 478 0.0337
189 SLEEP APNOEA SYNDROME 638 0.0334
190 DIZZINESS POSTURAL 324 0.0334
191 HOSPITALISATION 5130 0.0334
192 CATHETERISATION CARDIAC 148 0.0333
193 OBSTRUCTION 133 0.0333
194 EYE HAEMORRHAGE 444 0.0332
195 ARTHROPATHY 1848 0.0332
196 EMBOLISM 276 0.0332
197 HAEMATOCHEZIA 1833 0.0332
198 DIVERTICULUM INTESTINAL 145 0.0331
199 ANOSMIA 480 0.0331
200 PERICARDIAL EFFUSION 765 0.0331
201 MITRAL VALVE INCOMPETENCE 374 0.0330
202 NODULE 430 0.0329
203 CARPAL TUNNEL SYNDROME 459 0.0327
204 PROSTATIC DISORDER 179 0.0324
205 PERICARDITIS 545 0.0324
206 EXERCISE TOLERANCE DECREASED 185 0.0321
207 LEFT VENTRICULAR HYPERTROPHY 137 0.0320
208 BLOOD DISORDER 256 0.0319
209 ULCER HAEMORRHAGE 216 0.0319
210 BLOOD PRESSURE SYSTOLIC DECREASED 145 0.0318
211 ARRHYTHMIA 1502 0.0317
212 MACULAR DEGENERATION 378 0.0316
213 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 127 0.0311
214 CARDIAC FAILURE CONGESTIVE 2498 0.0311
215 NEOPLASM MALIGNANT 2074 0.0310
216 INCREASED TENDENCY TO BRUISE 283 0.0307
217 ANEURYSM 153 0.0307
218 ACUTE RESPIRATORY FAILURE 591 0.0307
219 PULMONARY HAEMORRHAGE 240 0.0307
220 PETECHIAE 319 0.0305
221 HYPOXIA 1076 0.0305
222 HAEMOGLOBIN DECREASED 3135 0.0305
223 BLOOD IRON DECREASED 358 0.0301
224 PERIPHERAL SWELLING 4622 0.0300
225 VARICOSE VEIN 154 0.0298
226 HAEMORRHAGIC ANAEMIA 131 0.0298
227 ACUTE KIDNEY INJURY 4559 0.0298
228 FALL 9795 0.0294
229 VEIN DISORDER 147 0.0293
230 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 181 0.0293
231 NEPHROPATHY 273 0.0292
232 DEATH 25095 0.0291
233 RENAL IMPAIRMENT 2447 0.0291
234 HEART RATE IRREGULAR 654 0.0289
235 AORTIC VALVE INCOMPETENCE 123 0.0289
236 PRODUCTIVE COUGH 1378 0.0288
237 HIP FRACTURE 928 0.0288
238 ATRIOVENTRICULAR BLOCK 223 0.0288
239 ANAEMIA 5500 0.0288
240 HYPOMAGNESAEMIA 398 0.0286
241 ORTHOSTATIC HYPOTENSION 497 0.0285
242 GASTRIC ULCER HAEMORRHAGE 158 0.0285
243 CARDIOGENIC SHOCK 407 0.0283
244 DIPLOPIA 733 0.0282
245 BACK DISORDER 458 0.0281
246 OXYGEN SATURATION DECREASED 1579 0.0281
247 PRODUCT PRESCRIBING ERROR 668 0.0280
248 TROPONIN INCREASED 211 0.0277
249 PROTEIN URINE PRESENT 138 0.0277
250 MULTIPLE ALLERGIES 217 0.0277
251 HAEMOGLOBIN ABNORMAL 177 0.0275
252 FEMORAL NECK FRACTURE 141 0.0275
253 GLOMERULAR FILTRATION RATE DECREASED 338 0.0275
254 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1319 0.0274
255 POLYP 179 0.0273
256 PERIPHERAL VENOUS DISEASE 111 0.0272
257 LIMB INJURY 738 0.0271
258 GASTRITIS EROSIVE 126 0.0270
259 PURPURA 239 0.0270
260 PELVIC FRACTURE 207 0.0266
261 HYPOTHYROIDISM 848 0.0265
262 BRADYCARDIA 1389 0.0262
263 WHEEZING 1548 0.0261
264 BLOOD PRESSURE ABNORMAL 517 0.0260
265 COVID-19 4548 0.0259
266 PULMONARY OEDEMA 1149 0.0256
267 COLON CANCER 378 0.0253
268 CEREBRAL ISCHAEMIA 130 0.0252
269 DIVERTICULUM 179 0.0252
270 ERYSIPELAS 126 0.0250
271 BLINDNESS 1021 0.0250
272 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1307 0.0250
273 BLOOD MAGNESIUM DECREASED 216 0.0250
274 FULL BLOOD COUNT DECREASED 503 0.0249
275 TRICUSPID VALVE INCOMPETENCE 196 0.0246
276 HAEMARTHROSIS 221 0.0246
277 HYPOTENSION 4920 0.0245
278 BLOOD PRESSURE DIASTOLIC DECREASED 181 0.0245
279 UROSEPSIS 226 0.0245
280 PAIN IN JAW 692 0.0244
281 HYDROCEPHALUS 133 0.0244
282 ENDOCARDITIS 125 0.0243
283 HYPERKALAEMIA 853 0.0243
284 EJECTION FRACTION DECREASED 378 0.0243
285 DEAFNESS 634 0.0242
286 IMMUNE THROMBOCYTOPENIA 111 0.0242
287 PRESCRIBED OVERDOSE 469 0.0242
288 STENT PLACEMENT 195 0.0242
289 INGUINAL HERNIA 147 0.0241
290 TASTE DISORDER 490 0.0241
291 HAEMOGLOBIN INCREASED 110 0.0241
292 DRUG INTERACTION 3823 0.0241
293 GASTRIC ULCER 457 0.0240
294 SPINAL DISORDER 227 0.0239
295 INFARCTION 164 0.0239
296 PHLEBITIS 122 0.0238
297 CONTRAINDICATED PRODUCT ADMINISTERED 720 0.0238
298 SINUS BRADYCARDIA 229 0.0237
299 HAEMORRHOIDS 460 0.0236
300 DECUBITUS ULCER 191 0.0234
301 HUMERUS FRACTURE 113 0.0234
302 LUNG DISORDER 1145 0.0233
303 PLEURAL EFFUSION 1415 0.0232
304 HEPATIC CYTOLYSIS 296 0.0232
305 HEART RATE INCREASED 2294 0.0231
306 HEART RATE DECREASED 811 0.0231
307 COAGULOPATHY 383 0.0230
308 DYSPNOEA 13002 0.0229
309 FLUID OVERLOAD 334 0.0229
310 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 116 0.0229
311 LEFT VENTRICULAR DYSFUNCTION 153 0.0228
312 HEMIPARESIS 381 0.0225
313 PRODUCT ADMINISTRATION INTERRUPTED 176 0.0224
314 LYMPHOEDEMA 155 0.0224
315 OEDEMA PERIPHERAL 2728 0.0224
316 MUSCLE TWITCHING 515 0.0223
317 PULMONARY FIBROSIS 426 0.0222
318 LIP SWELLING 738 0.0221
319 HYPOKALAEMIA 1016 0.0220
320 ELECTROLYTE IMBALANCE 255 0.0219
321 SPUTUM DISCOLOURED 207 0.0218
322 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 728 0.0215
323 BLOOD PRESSURE FLUCTUATION 517 0.0215
324 RESPIRATION ABNORMAL 148 0.0215
325 DERMATITIS CONTACT 244 0.0214
326 PLATELET COUNT ABNORMAL 129 0.0213
327 LACERATION 200 0.0212
328 SYNCOPE 2124 0.0212
329 RALES 123 0.0212
330 AORTIC ANEURYSM 161 0.0211
331 HAEMODYNAMIC INSTABILITY 161 0.0211
332 SKIN HAEMORRHAGE 313 0.0211
333 RIB FRACTURE 434 0.0211
334 ANGIOPATHY 118 0.0210
335 RESPIRATORY TRACT CONGESTION 332 0.0209
336 COGNITIVE DISORDER 975 0.0209
337 INTERSTITIAL LUNG DISEASE 1008 0.0208
338 FAECES SOFT 151 0.0207
339 INTENTIONAL UNDERDOSE 150 0.0205
340 CHOLESTASIS 393 0.0204
341 ELECTROCARDIOGRAM ABNORMAL 160 0.0204
342 SKIN ATROPHY 117 0.0203
343 GENERAL PHYSICAL HEALTH DETERIORATION 2344 0.0202
344 PNEUMONIA ASPIRATION 506 0.0202
345 CONCOMITANT DISEASE AGGRAVATED 125 0.0202
346 OESOPHAGITIS 221 0.0202
347 HAEMATOCRIT DECREASED 401 0.0202
348 BLOOD PRESSURE DECREASED 1343 0.0202
349 UPPER-AIRWAY COUGH SYNDROME 166 0.0201
350 ACUTE PULMONARY OEDEMA 113 0.0201
351 HYPONATRAEMIA 1132 0.0201
352 CLOSTRIDIUM DIFFICILE COLITIS 213 0.0201
353 DEHYDRATION 2677 0.0200
354 PROTHROMBIN TIME PROLONGED 120 0.0200
355 THYROID DISORDER 308 0.0200
356 PNEUMONIA 6443 0.0199
357 OEDEMA 1070 0.0197
358 HERNIA 381 0.0197
359 SMALL INTESTINAL OBSTRUCTION 242 0.0196
360 RED BLOOD CELL COUNT DECREASED 561 0.0196
361 CEREBRAL DISORDER 145 0.0196
362 FACIAL PARALYSIS 167 0.0196
363 RASH PAPULAR 439 0.0196
364 HEMIPLEGIA 162 0.0195
365 HIATUS HERNIA 252 0.0194
366 GAIT INABILITY 647 0.0193
367 URINARY TRACT INFECTION 3278 0.0192
368 CARDIAC OPERATION 165 0.0192
369 THERAPY INTERRUPTED 1370 0.0192
370 EYE PRURITUS 642 0.0191
371 TINNITUS 877 0.0191
372 CORONAVIRUS INFECTION 126 0.0190
373 ACUTE MYOCARDIAL INFARCTION 561 0.0190
374 LOCALISED INFECTION 460 0.0190
375 LACTIC ACIDOSIS 616 0.0190
376 ANAL INCONTINENCE 171 0.0190
377 BLOOD CREATININE INCREASED 1241 0.0190
378 PAIN OF SKIN 511 0.0190
379 PRODUCT DISPENSING ERROR 413 0.0189
380 INTERVERTEBRAL DISC DEGENERATION 175 0.0189
381 BLOOD POTASSIUM INCREASED 307 0.0189
382 MULTIPLE ORGAN DYSFUNCTION SYNDROME 535 0.0189
383 LIMB DISCOMFORT 583 0.0188
384 SCIATICA 300 0.0188
385 THERAPY CHANGE 185 0.0188
386 BLOOD COUNT ABNORMAL 283 0.0186
387 CHROMATURIA 421 0.0186
388 HALLUCINATION 1401 0.0186
389 MUSCULAR WEAKNESS 2101 0.0185
390 CATARACT 1098 0.0184
391 CELLULITIS 928 0.0184
392 HYPERTHYROIDISM 266 0.0184
393 DECREASED ACTIVITY 198 0.0183
394 PERIPHERAL COLDNESS 252 0.0183
395 COUGH 5145 0.0183
396 WHITE BLOOD CELL COUNT ABNORMAL 117 0.0183
397 BLOOD POTASSIUM DECREASED 551 0.0183
398 RESPIRATORY SYNCYTIAL VIRUS INFECTION 158 0.0181
399 SKIN ULCER 468 0.0181
400 POLYURIA 148 0.0181
401 DIZZINESS 9007 0.0180
402 PALPITATIONS 2099 0.0179
403 ASPIRATION 196 0.0179
404 TACHYCARDIA 1589 0.0179
405 CLOSTRIDIUM DIFFICILE INFECTION 389 0.0178
406 LOWER LIMB FRACTURE 342 0.0178
407 ATRIOVENTRICULAR BLOCK COMPLETE 119 0.0178
408 SPINAL FRACTURE 356 0.0177
409 PRODUCT DOSE OMISSION IN ERROR 503 0.0177
410 MYASTHENIA GRAVIS 143 0.0177
411 LIGAMENT SPRAIN 175 0.0177
412 NEOPLASM 202 0.0176
413 PRODUCT DISTRIBUTION ISSUE 163 0.0176
414 PNEUMONIA BACTERIAL 161 0.0175
415 ACUTE CORONARY SYNDROME 145 0.0175
416 SUDDEN DEATH 185 0.0175
417 WEIGHT DECREASED 4871 0.0174
418 ASTHENIA 6556 0.0174
419 SPINAL COMPRESSION FRACTURE 144 0.0174
420 ACCIDENT 207 0.0173
421 SINUS DISORDER 343 0.0173
422 END STAGE RENAL DISEASE 315 0.0173
423 CHEST PAIN 3195 0.0172
424 PRESYNCOPE 418 0.0172
425 BRAIN FOG 269 0.0171
426 CIRCULATORY COLLAPSE 292 0.0171
427 APHASIA 517 0.0171
428 HEAD DISCOMFORT 302 0.0170
429 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1212 0.0170
430 SEPSIS 1900 0.0170
431 SEPTIC SHOCK 741 0.0170
432 THROMBOCYTOPENIA 1903 0.0170
433 SKIN DISCOLOURATION 780 0.0170
434 FIBROMYALGIA 411 0.0169
435 DEVICE RELATED INFECTION 260 0.0169
436 GROIN PAIN 148 0.0168
437 CARDIOMYOPATHY 249 0.0168
438 PULMONARY CONGESTION 222 0.0168
439 AMNESIA 1093 0.0168
440 TOOTH FRACTURE 185 0.0168
441 MYOCARDIAL INFARCTION 2926 0.0168
442 ABNORMAL LOSS OF WEIGHT 114 0.0167
443 WOUND 466 0.0167
444 ARTERIAL OCCLUSIVE DISEASE 131 0.0166
445 RENAL FAILURE 2196 0.0165
446 BLADDER DISORDER 164 0.0165
447 GASTROOESOPHAGEAL REFLUX DISEASE 1329 0.0165
448 ABNORMAL FAECES 135 0.0165
449 ASTHMA 1857 0.0164
450 BLOOD ALBUMIN DECREASED 130 0.0164
451 MEMORY IMPAIRMENT 2249 0.0164
452 BACK INJURY 178 0.0164
453 BOWEL MOVEMENT IRREGULARITY 125 0.0163
454 ANGIOEDEMA 721 0.0163
455 CHOLECYSTITIS 194 0.0163
456 BEDRIDDEN 214 0.0163
457 CORONARY ARTERY DISEASE 491 0.0162
458 EXTRASYSTOLES 113 0.0162
459 URINARY RETENTION 540 0.0162
460 RASH MACULO-PAPULAR 360 0.0162
461 ARTHRITIS 1268 0.0161
462 PLASMA CELL MYELOMA 628 0.0161
463 FATIGUE 12518 0.0161
464 PEMPHIGOID 121 0.0160
465 DECREASED APPETITE 3724 0.0160
466 EYE DISORDER 527 0.0160
467 UPPER LIMB FRACTURE 319 0.0160
468 VENTRICULAR EXTRASYSTOLES 166 0.0160
469 ULCER 254 0.0159
470 MUSCLE STRAIN 138 0.0159
471 PRODUCT ADMINISTRATION ERROR 322 0.0159
472 VISUAL IMPAIRMENT 1973 0.0159
473 DIARRHOEA 10264 0.0159
474 INCONTINENCE 168 0.0159
475 PNEUMOTHORAX 252 0.0159
476 GENERALISED OEDEMA 195 0.0157
477 BACK PAIN 3653 0.0157
478 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 161 0.0157
479 COMPLICATION ASSOCIATED WITH DEVICE 227 0.0156
480 DIVERTICULITIS 433 0.0156
481 RASH MACULAR 545 0.0156
482 LEUKAEMIA 147 0.0156
483 BLOOD SODIUM DECREASED 293 0.0155
484 TACHYPNOEA 211 0.0155
485 TUBULOINTERSTITIAL NEPHRITIS 290 0.0155
486 INTERNATIONAL NORMALISED RATIO INCREASED 441 0.0155
487 PROSTATIC SPECIFIC ANTIGEN INCREASED 213 0.0154
488 BLOOD PRESSURE SYSTOLIC INCREASED 301 0.0154
489 HYPOCALCAEMIA 292 0.0154
490 ATELECTASIS 149 0.0154
491 BACTERAEMIA 183 0.0154
492 HYPERTENSION 3262 0.0154
493 HEPATOCELLULAR INJURY 218 0.0154
494 FLANK PAIN 144 0.0153
495 PHARYNGEAL SWELLING 150 0.0153
496 NOCTURIA 186 0.0153
497 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 119 0.0153
498 AGEUSIA 382 0.0153
499 HYPERTENSIVE CRISIS 170 0.0153
500 PLATELET COUNT DECREASED 1627 0.0152
501 SECRETION DISCHARGE 191 0.0152
502 HYPOTHERMIA 154 0.0152
503 RESPIRATORY FAILURE 1104 0.0151
504 GLAUCOMA 291 0.0151
505 INSURANCE ISSUE 231 0.0151
506 DIALYSIS 214 0.0151
507 EMPHYSEMA 152 0.0151
508 HYPERLIPIDAEMIA 180 0.0150
509 ILLNESS 1550 0.0150
510 PULMONARY MASS 224 0.0150
511 NEUROPATHY PERIPHERAL 1430 0.0150
512 FEELING COLD 418 0.0150
513 MEDICATION ERROR 833 0.0150
514 CONFUSIONAL STATE 2422 0.0150
515 CYSTITIS 477 0.0150
516 DYSPHONIA 876 0.0150
517 CARDIOMEGALY 184 0.0149
518 CONSTIPATION 3262 0.0149
519 ANGINA PECTORIS 427 0.0149
520 BLOOD UREA INCREASED 249 0.0149
521 CHEST DISCOMFORT 1518 0.0148
522 PAIN IN EXTREMITY 4365 0.0148
523 HYPOALBUMINAEMIA 115 0.0148
524 BALANCE DISORDER 1276 0.0147
525 NEPHROLITHIASIS 677 0.0147
526 LEUKOCYTOSIS 267 0.0147
527 SURGERY 862 0.0147
528 WOUND INFECTION 161 0.0147
529 SCRATCH 155 0.0147
530 BASAL CELL CARCINOMA 229 0.0147
531 PALLOR 399 0.0146
532 ASCITES 431 0.0146
533 INTENTIONAL PRODUCT MISUSE 1282 0.0146
534 DYSURIA 539 0.0146
535 ANKLE FRACTURE 226 0.0146
536 GALLBLADDER DISORDER 260 0.0146
537 ABDOMINAL DISCOMFORT 2440 0.0145
538 RHINORRHOEA 940 0.0145
539 BLOOD PRESSURE INCREASED 2223 0.0145
540 BRONCHITIS 1076 0.0145
541 KIDNEY INFECTION 285 0.0145
542 WRIST FRACTURE 174 0.0145
543 EOSINOPHILIA 254 0.0145
544 DISTURBANCE IN ATTENTION 781 0.0145
545 POLLAKIURIA 603 0.0144
546 LUNG NEOPLASM MALIGNANT 594 0.0144
547 DEVICE OCCLUSION 203 0.0144
548 JOINT INJURY 308 0.0144
549 SUPRAVENTRICULAR TACHYCARDIA 138 0.0144
550 NERVE COMPRESSION 133 0.0144
551 MUSCULOSKELETAL CHEST PAIN 223 0.0144
552 MALNUTRITION 161 0.0144
553 RASH PRURITIC 779 0.0144
554 DRY THROAT 146 0.0144
555 ENCEPHALOPATHY 352 0.0143
556 DIARRHOEA HAEMORRHAGIC 133 0.0142
557 CHRONIC KIDNEY DISEASE 1081 0.0142
558 COLITIS 539 0.0142
559 PANCYTOPENIA 791 0.0141
560 OFF LABEL USE 12368 0.0141
561 SKIN DISORDER 471 0.0141
562 SCAB 161 0.0141
563 POST PROCEDURAL COMPLICATION 271 0.0141
564 OCULAR DISCOMFORT 158 0.0141
565 DELIRIUM 488 0.0140
566 GASTRITIS 370 0.0140
567 RESPIRATORY TRACT INFECTION 365 0.0140
568 FEEDING DISORDER 282 0.0139
569 HICCUPS 114 0.0139
570 MUSCULOSKELETAL DISCOMFORT 239 0.0139
571 HYPERSOMNIA 398 0.0139
572 HALLUCINATION, VISUAL 293 0.0139
573 URINARY INCONTINENCE 411 0.0139
574 RENAL CYST 110 0.0138
575 LOSS OF CONSCIOUSNESS 1772 0.0138
576 NASAL CONGESTION 812 0.0138
577 FLATULENCE 783 0.0138
578 DYSPHAGIA 1306 0.0137
579 GASTROINTESTINAL DISORDER 1232 0.0137
580 SWELLING 1286 0.0137
581 PNEUMONITIS 374 0.0137
582 POST PROCEDURAL INFECTION 111 0.0136
583 CYTOPENIA 167 0.0136
584 FRACTURE 258 0.0136
585 OROPHARYNGEAL DISCOMFORT 123 0.0136
586 AGRANULOCYTOSIS 253 0.0136
587 BRAIN NEOPLASM 125 0.0136
588 LIVER FUNCTION TEST INCREASED 291 0.0135
589 FEMUR FRACTURE 417 0.0135
590 THERAPY NON-RESPONDER 604 0.0134
591 CARDIAC ARREST 1101 0.0133
592 ABDOMINAL PAIN UPPER 2743 0.0133
593 OSTEOARTHRITIS 564 0.0133
594 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 342 0.0133
595 CORONARY ARTERY OCCLUSION 182 0.0133
596 URINE OUTPUT DECREASED 116 0.0133
597 ELECTROCARDIOGRAM QT PROLONGED 476 0.0132
598 PANCREATITIS ACUTE 297 0.0132
599 BLINDNESS UNILATERAL 186 0.0132
600 RETCHING 281 0.0132
601 DYSARTHRIA 496 0.0132
602 ACUTE RESPIRATORY DISTRESS SYNDROME 233 0.0132
603 PRODUCT DOSE OMISSION 859 0.0131
604 ANURIA 113 0.0131
605 TOOTH INFECTION 173 0.0131
606 CYTOKINE RELEASE SYNDROME 263 0.0131
607 SINUS CONGESTION 177 0.0131
608 OBESITY 208 0.0130
609 GAIT DISTURBANCE 2498 0.0130
610 PLATELET COUNT INCREASED 170 0.0130
611 NECK PAIN 726 0.0130
612 ORAL PAIN 290 0.0129
613 MENTAL STATUS CHANGES 359 0.0129
614 ARTHRALGIA 5364 0.0129
615 SHOCK 296 0.0129
616 VERTIGO 784 0.0129
617 RESPIRATORY DISTRESS 354 0.0128
618 MYOCARDITIS 147 0.0128
619 BODY TEMPERATURE DECREASED 126 0.0128
620 DIABETES MELLITUS 974 0.0128
621 HEPATIC CIRRHOSIS 240 0.0128
622 HYPOPHAGIA 326 0.0127
623 HEADACHE 7976 0.0127
624 RESTLESS LEGS SYNDROME 230 0.0126
625 MALAISE 5546 0.0126
626 FOOT FRACTURE 239 0.0126
627 SARS-COV-2 TEST POSITIVE 166 0.0126
628 LABORATORY TEST ABNORMAL 370 0.0125
629 SQUAMOUS CELL CARCINOMA 118 0.0125
630 GASTRIC DISORDER 430 0.0125
631 SPINAL OSTEOARTHRITIS 110 0.0125
632 UNRESPONSIVE TO STIMULI 323 0.0125
633 DRUG LEVEL INCREASED 207 0.0125
634 TOOTH ABSCESS 127 0.0125
635 POOR VENOUS ACCESS 129 0.0125
636 MYOCARDIAL ISCHAEMIA 141 0.0124
637 HYPERBILIRUBINAEMIA 128 0.0123
638 CYANOSIS 194 0.0123
639 HYPOTONIA 123 0.0123
640 CANDIDA INFECTION 208 0.0123
641 SKIN CANCER 265 0.0123
642 PRURITUS 4728 0.0123
643 DYSSTASIA 358 0.0122
644 PRODUCT DOSE OMISSION ISSUE 3605 0.0122
645 HEAVY MENSTRUAL BLEEDING 110 0.0122
646 FREQUENT BOWEL MOVEMENTS 330 0.0122
647 JOINT SWELLING 1474 0.0122
648 BURNING SENSATION 856 0.0122
649 PRODUCT USE COMPLAINT 192 0.0122
650 DYSPEPSIA 1195 0.0121
651 MUSCULOSKELETAL PAIN 634 0.0121
652 INTENTIONAL DOSE OMISSION 344 0.0121
653 HYPOKINESIA 175 0.0120
654 PARALYSIS 172 0.0120
655 EAR DISCOMFORT 123 0.0120
656 RENAL PAIN 127 0.0120
657 DIABETES MELLITUS INADEQUATE CONTROL 212 0.0120
658 TOOTH EXTRACTION 148 0.0119
659 INFLUENZA 1323 0.0119
660 THROAT IRRITATION 531 0.0118
661 ABDOMINAL DISTENSION 1229 0.0118
662 BRAIN INJURY 118 0.0118
663 SLUGGISHNESS 120 0.0118
664 POOR QUALITY SLEEP 253 0.0117
665 LETHARGY 675 0.0117
666 ADRENAL INSUFFICIENCY 142 0.0117
667 INTESTINAL OBSTRUCTION 441 0.0117
668 SPINAL PAIN 137 0.0117
669 CONDITION AGGRAVATED 3546 0.0117
670 BLOOD CALCIUM DECREASED 131 0.0116
671 ACCIDENTAL OVERDOSE 426 0.0116
672 MICTURITION URGENCY 133 0.0116
673 FEELING ABNORMAL 2790 0.0116
674 NEURALGIA 283 0.0116
675 WEIGHT INCREASED 2604 0.0116
676 MOUTH ULCERATION 245 0.0116
677 APHONIA 162 0.0116
678 NASOPHARYNGITIS 2136 0.0116
679 VITAMIN D DEFICIENCY 113 0.0116
680 BACTERIAL INFECTION 216 0.0116
681 TOXIC SKIN ERUPTION 116 0.0115
682 OROPHARYNGEAL PAIN 1066 0.0115
683 DRY MOUTH 934 0.0115
684 PHOTOSENSITIVITY REACTION 190 0.0115
685 RESPIRATORY DISORDER 343 0.0115
686 EYE PAIN 646 0.0114
687 INSOMNIA 3049 0.0114
688 TOOTHACHE 207 0.0114
689 PRODUCT PRESCRIBING ISSUE 249 0.0114
690 CARDIO-RESPIRATORY ARREST 477 0.0114
691 DEPRESSED LEVEL OF CONSCIOUSNESS 451 0.0114
692 GAMMA-GLUTAMYLTRANSFERASE INCREASED 252 0.0114
693 ALOPECIA 2233 0.0114
694 PRODUCT USE ISSUE 2134 0.0113
695 MYALGIA 1930 0.0113
696 VENTRICULAR FIBRILLATION 126 0.0113
697 WHITE BLOOD CELL COUNT DECREASED 1225 0.0113
698 PRODUCT STORAGE ERROR 987 0.0113
699 SPEECH DISORDER 589 0.0112
700 TENDERNESS 117 0.0112
701 SLEEP DISORDER 792 0.0112
702 OSTEOPOROSIS 461 0.0112
703 SPLENOMEGALY 131 0.0112
704 MIGRAINE 1067 0.0112
705 OSTEOMYELITIS 202 0.0111
706 JAUNDICE 300 0.0111
707 DELUSION 173 0.0111
708 NAUSEA 8776 0.0111
709 C-REACTIVE PROTEIN INCREASED 403 0.0111
710 EYE INFECTION 125 0.0111
711 ROAD TRAFFIC ACCIDENT 463 0.0111
712 HYPERGLYCAEMIA 401 0.0110
713 DISORIENTATION 435 0.0110
714 UPPER RESPIRATORY TRACT INFECTION 507 0.0110
715 KNEE ARTHROPLASTY 231 0.0110
716 GASTROENTERITIS VIRAL 198 0.0110
717 RASH 4767 0.0109
718 NERVE INJURY 121 0.0109
719 HOT FLUSH 817 0.0108
720 HYPOAESTHESIA 1620 0.0108
721 MOTOR DYSFUNCTION 110 0.0108
722 INFECTION 1561 0.0108
723 ROTATOR CUFF SYNDROME 138 0.0107
724 MOBILITY DECREASED 769 0.0107
725 ILEUS 133 0.0107
726 STAPHYLOCOCCAL INFECTION 353 0.0107
727 SNEEZING 240 0.0107
728 HYPERHIDROSIS 1372 0.0106
729 METABOLIC ACIDOSIS 340 0.0106
730 CHOKING 207 0.0106
731 POLYNEUROPATHY 127 0.0106
732 BURSITIS 128 0.0105
733 HERPES ZOSTER 605 0.0105
734 COMA 500 0.0105
735 ABDOMINAL PAIN 2431 0.0104
736 STOMATITIS 633 0.0104
737 DRUG PRESCRIBING ERROR 200 0.0104
738 LIVER FUNCTION TEST ABNORMAL 302 0.0104
739 MASS 145 0.0104
740 LIVER DISORDER 460 0.0104
741 MUSCLE SPASMS 1901 0.0103
742 RED BLOOD CELL SEDIMENTATION RATE INCREASED 114 0.0103
743 BRAIN OEDEMA 130 0.0103
744 LYMPHOMA 159 0.0103
745 BLISTER 577 0.0103
746 SKIN LESION 281 0.0102
747 NIGHT SWEATS 330 0.0102
748 VAGINAL HAEMORRHAGE 444 0.0102
749 DENTAL CARIES 113 0.0102
750 LACRIMATION INCREASED 308 0.0102
751 HIP ARTHROPLASTY 156 0.0102
752 GASTROINTESTINAL PAIN 112 0.0102
753 FEBRILE NEUTROPENIA 674 0.0101
754 SWOLLEN TONGUE 317 0.0101
755 GASTROENTERITIS 148 0.0101
756 HYPERCALCAEMIA 125 0.0101
757 HYPOGLYCAEMIA 491 0.0101
758 VOMITING 4756 0.0101
759 IMPAIRED HEALING 332 0.0101
760 PARAESTHESIA 1587 0.0101
761 DRUG-INDUCED LIVER INJURY 316 0.0101
762 CHOLELITHIASIS 329 0.0100
763 ADVERSE DRUG REACTION 897 0.0100
764 ERUCTATION 193 0.0100
765 HEPATIC FAILURE 299 0.0099
766 SWELLING FACE 644 0.0099
767 TENDON RUPTURE 122 0.0099
768 MOVEMENT DISORDER 317 0.0099
769 DRY SKIN 1314 0.0098
770 THIRST 175 0.0098
771 BLOOD ALKALINE PHOSPHATASE INCREASED 243 0.0098
772 APATHY 142 0.0097
773 NEUTROPENIA 1320 0.0097
774 PYREXIA 3359 0.0097
775 MUSCLE TIGHTNESS 157 0.0097
776 TREMOR 1608 0.0097
777 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1745 0.0097
778 DISABILITY 191 0.0096
779 EXTRA DOSE ADMINISTERED 390 0.0096
780 EATING DISORDER 205 0.0096
781 THERAPY CESSATION 493 0.0096
782 SOMNOLENCE 1914 0.0095
783 SPINAL OPERATION 117 0.0095
784 DERMATITIS ALLERGIC 119 0.0095
785 BONE DISORDER 172 0.0094
786 VIRAL INFECTION 313 0.0094
787 MALIGNANT NEOPLASM PROGRESSION 963 0.0094
788 MYELODYSPLASTIC SYNDROME 136 0.0094
789 PRODUCT AVAILABILITY ISSUE 214 0.0094
790 BONE PAIN 550 0.0094
791 ALTERED STATE OF CONSCIOUSNESS 203 0.0094
792 DRUG ERUPTION 166 0.0094
793 BLOOD BILIRUBIN INCREASED 253 0.0094
794 LOWER RESPIRATORY TRACT INFECTION 425 0.0093
795 DRUG INTOLERANCE 902 0.0093
796 MALIGNANT MELANOMA 125 0.0093
797 MUSCLE ATROPHY 118 0.0093
798 OCULAR HYPERAEMIA 441 0.0093
799 PAIN 5677 0.0092
800 ACUTE HEPATIC FAILURE 126 0.0092
801 CARDIOVASCULAR DISORDER 234 0.0092
802 ANXIETY 2623 0.0092
803 WHITE BLOOD CELL COUNT INCREASED 353 0.0092
804 INFLAMMATION 473 0.0092
805 PRODUCT PHYSICAL ISSUE 184 0.0091
806 SINUSITIS 934 0.0091
807 ABDOMINAL PAIN LOWER 230 0.0091
808 RHABDOMYOLYSIS 379 0.0091
809 METASTASES TO CENTRAL NERVOUS SYSTEM 117 0.0091
810 DRY EYE 451 0.0090
811 CYST 112 0.0090
812 METASTASES TO BONE 147 0.0089
813 NEUTROPHIL COUNT DECREASED 365 0.0089
814 NEOPLASM PROGRESSION 310 0.0089
815 PHOTOPHOBIA 167 0.0089
816 VISION BLURRED 1218 0.0089
817 COLD SWEAT 156 0.0088
818 DISCOMFORT 539 0.0088
819 CHILLS 1033 0.0088
820 ORAL CANDIDIASIS 116 0.0088
821 JOINT STIFFNESS 230 0.0088
822 DISEASE PROGRESSION 1026 0.0087
823 FUNGAL INFECTION 289 0.0087
824 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 202 0.0087
825 RASH ERYTHEMATOUS 413 0.0086
826 BLOOD GLUCOSE ABNORMAL 159 0.0086
827 MENORRHAGIA 169 0.0086
828 DISSEMINATED INTRAVASCULAR COAGULATION 121 0.0086
829 ABSCESS 137 0.0086
830 SEIZURE 986 0.0085
831 IMMUNE SYSTEM DISORDER 112 0.0085
832 HYPOAESTHESIA ORAL 128 0.0085
833 HEPATITIS 214 0.0084
834 IMPAIRED GASTRIC EMPTYING 114 0.0084
835 THERAPY PARTIAL RESPONDER 130 0.0083
836 INTERVERTEBRAL DISC PROTRUSION 182 0.0083
837 INCORRECT PRODUCT ADMINISTRATION DURATION 180 0.0083
838 METASTASES TO LIVER 146 0.0083
839 EAR PAIN 161 0.0083
840 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1678 0.0083
841 MUSCULOSKELETAL STIFFNESS 725 0.0083
842 BODY TEMPERATURE INCREASED 168 0.0082
843 PANCREATIC CARCINOMA 237 0.0082
844 NERVOUSNESS 428 0.0082
845 TRANSAMINASES INCREASED 182 0.0082
846 PRODUCT USE IN UNAPPROVED INDICATION 2023 0.0082
847 HEPATIC STEATOSIS 152 0.0082
848 HEPATIC ENZYME INCREASED 554 0.0081
849 SKIN EXFOLIATION 685 0.0081
850 PROCEDURAL PAIN 225 0.0081
851 LEUKOPENIA 405 0.0081
852 ORAL HERPES 157 0.0080
853 SKIN REACTION 112 0.0079
854 RESTLESSNESS 290 0.0079
855 FEELING JITTERY 151 0.0079
856 EYE IRRITATION 453 0.0079
857 DYSGEUSIA 584 0.0079
858 IMMUNODEFICIENCY 117 0.0078
859 EPILEPSY 237 0.0077
860 UNDERDOSE 560 0.0077
861 FEELING HOT 470 0.0077
862 DRUG EFFECT LESS THAN EXPECTED 113 0.0076
863 GLYCOSYLATED HAEMOGLOBIN INCREASED 192 0.0076
864 FLUSHING 768 0.0075
865 SYSTEMIC LUPUS ERYTHEMATOSUS 266 0.0075
866 MENTAL IMPAIRMENT 181 0.0075
867 MIDDLE INSOMNIA 139 0.0074
868 EAR INFECTION 198 0.0074
869 BLOOD GLUCOSE INCREASED 1401 0.0074
870 UNEVALUABLE EVENT 562 0.0074
871 ECZEMA 386 0.0074
872 STEVENS-JOHNSON SYNDROME 163 0.0073
873 ERECTILE DYSFUNCTION 187 0.0073
874 HYPERSENSITIVITY 1348 0.0073
875 IRRITABLE BOWEL SYNDROME 155 0.0072
876 DEPRESSED MOOD 381 0.0072
877 THINKING ABNORMAL 134 0.0072
878 EYE SWELLING 267 0.0072
879 SKIN FISSURES 139 0.0071
880 SENSORY DISTURBANCE 114 0.0071
881 EXPIRED PRODUCT ADMINISTERED 236 0.0071
882 MUSCULOSKELETAL DISORDER 135 0.0071
883 LIVER INJURY 173 0.0070
884 LYMPHADENOPATHY 245 0.0069
885 ERYTHEMA 1420 0.0069
886 LYMPHOCYTE COUNT DECREASED 122 0.0069
887 URTICARIA 1144 0.0068
888 THERAPEUTIC RESPONSE UNEXPECTED 306 0.0068
889 ANAPHYLACTIC REACTION 376 0.0068
890 ASPARTATE AMINOTRANSFERASE INCREASED 360 0.0068
891 DEVICE DISLOCATION 288 0.0066
892 PARANOIA 114 0.0066
893 TYPE 2 DIABETES MELLITUS 222 0.0066
894 HEPATIC FUNCTION ABNORMAL 246 0.0066
895 BLOOD CHOLESTEROL INCREASED 306 0.0066
896 DEPRESSION 1493 0.0066
897 CONJUNCTIVITIS 121 0.0065
898 DYSKINESIA 264 0.0065
899 INTENTIONAL OVERDOSE 416 0.0065
900 ALANINE AMINOTRANSFERASE INCREASED 398 0.0065
901 GLOSSODYNIA 144 0.0064
902 PANCREATITIS 339 0.0064
903 RESPIRATORY ARREST 172 0.0062
904 BLOOD GLUCOSE DECREASED 299 0.0062
905 INCORRECT DOSE ADMINISTERED 1417 0.0062
906 MUCOSAL INFLAMMATION 161 0.0061
907 DIABETIC KETOACIDOSIS 147 0.0061
908 BLOOD CREATINE PHOSPHOKINASE INCREASED 175 0.0061
909 AGITATION 446 0.0061
910 PSYCHOTIC DISORDER 178 0.0060
911 RASH GENERALISED 156 0.0060
912 NIGHTMARE 208 0.0060
913 PROTEINURIA 113 0.0059
914 COLITIS ULCERATIVE 264 0.0059
915 INFUSION RELATED REACTION 390 0.0059
916 PRURITUS GENERALISED 126 0.0058
917 RENAL INJURY 172 0.0058
918 INCREASED APPETITE 110 0.0058
919 SUICIDE ATTEMPT 349 0.0058
920 DISEASE RECURRENCE 273 0.0057
921 TOXICITY TO VARIOUS AGENTS 961 0.0057
922 TREATMENT FAILURE 472 0.0057
923 PANIC ATTACK 206 0.0056
924 ILL-DEFINED DISORDER 343 0.0056
925 DERMATITIS 118 0.0056
926 THROAT TIGHTNESS 152 0.0056
927 GASTRIC CANCER 142 0.0056
928 NO ADVERSE EVENT 1011 0.0056
929 HEPATIC CANCER 134 0.0056
930 HEPATOTOXICITY 122 0.0055
931 THERAPEUTIC PRODUCT EFFECT DECREASED 238 0.0053
932 THERAPEUTIC RESPONSE SHORTENED 176 0.0053
933 DRUG ADMINISTRATION ERROR 161 0.0052
934 RHEUMATOID ARTHRITIS 595 0.0052
935 PROSTATE CANCER 405 0.0050
936 INFLUENZA LIKE ILLNESS 411 0.0050
937 FEAR 134 0.0050
938 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 273 0.0050
939 INJURY 349 0.0050
940 DEVICE LEAKAGE 206 0.0047
941 MENTAL DISORDER 205 0.0047
942 NERVOUS SYSTEM DISORDER 147 0.0047
943 DEVICE MALFUNCTION 326 0.0046
944 ABNORMAL DREAMS 127 0.0046
945 DRUG INEFFECTIVE 6037 0.0046
946 DRUG DOSE OMISSION 753 0.0046
947 INJECTION SITE BRUISING 363 0.0045
948 NEEDLE ISSUE 132 0.0045
949 SKIN IRRITATION 207 0.0045
950 ANAPHYLACTIC SHOCK 116 0.0045
951 DEVICE ISSUE 390 0.0043
952 SUICIDAL IDEATION 393 0.0043
953 SEDATION 110 0.0042
954 VISUAL ACUITY REDUCED 137 0.0041
955 BREAST CANCER 380 0.0041
956 INJECTION SITE HAEMORRHAGE 325 0.0041
957 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 287 0.0040
958 OVERDOSE 849 0.0039
959 PSORIATIC ARTHROPATHY 157 0.0039
960 DEVICE USE ERROR 134 0.0039
961 BLADDER CANCER 225 0.0038
962 EMOTIONAL DISORDER 116 0.0038
963 ABNORMAL BEHAVIOUR 149 0.0038
964 PSORIASIS 486 0.0037
965 PRODUCT SUBSTITUTION ISSUE 203 0.0035
966 COMPLETED SUICIDE 284 0.0034
967 AGGRESSION 169 0.0034
968 MYELOSUPPRESSION 120 0.0033
969 INJECTION SITE MASS 122 0.0033
970 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 152 0.0033
971 IRRITABILITY 194 0.0032
972 THERAPEUTIC RESPONSE DECREASED 189 0.0031
973 ACNE 225 0.0030
974 DEVICE BREAKAGE 120 0.0030
975 MULTIPLE SCLEROSIS 139 0.0029
976 INJECTION SITE PRURITUS 180 0.0027
977 DERMATITIS ATOPIC 140 0.0027
978 INJECTION SITE SWELLING 198 0.0026
979 INJECTION SITE PAIN 765 0.0025
980 RENAL CANCER 118 0.0025
981 PRODUCT QUALITY ISSUE 334 0.0025
982 INJECTION SITE ERYTHEMA 299 0.0024
983 ACCIDENTAL EXPOSURE TO PRODUCT 245 0.0024
984 DEVICE DIFFICULT TO USE 147 0.0022
985 DRUG ABUSE 176 0.0021
986 SKIN BURNING SENSATION 142 0.0020
987 MATERNAL EXPOSURE DURING PREGNANCY 176 0.0020
988 EMOTIONAL DISTRESS 211 0.0017
989 MULTIPLE SCLEROSIS RELAPSE 115 0.0017
990 INJECTION SITE REACTION 114 0.0017
991 DRUG DOSE OMISSION BY DEVICE 126 0.0016